Journal of Practical Hepatology ›› 2022, Vol. 25 ›› Issue (3): 443-446.doi: 10.3969/j.issn.1672-5069.2022.03.035

• Liver cyst • Previous Articles     Next Articles

Relapse of hepatic cysts after laparoscopic fenestration drainage or ultrasound-guided puncture sclerotherapy therapy: a three-month followed-up

Li Wenqiang, Cheng Chunxia, Xu Dongmei   

  1. Functional Department. Traditional Chinese Medicine Hospital, Luzhou 646000, Sichuan Province, China
  • Received:2021-09-08 Online:2022-05-10 Published:2022-05-17

Abstract: Objective The aim of this study was to compare the relapse of hepatic cysts (HC) after laparoscopic fenestration drainage (LFD) or ultrasound-guided puncture sclerotherapy (US-GPS) therapy in patients with HC, and the impact on serum myocardial enzymes and platelet parameters. Methods A total of 65 patients with HC were encountered in our hospital between January 2016 and December 2020, and 31 patients received LFD and 34 patients received US-GPS therapy. All patients were followed-up for three months. Serum creatine phosphokinase (CK), myokinase isoenzyme (CK-MB) and lactate dehydrogenase (LDH)] were assayed, and peripheral blood platelet counts (PLT), thrombocytocrit (PCT), platelet distribution width (PDW) and mean platelet volume (MPV) were detected routinely. Results Three days after operation, serum myocardial enzymes increased compared to those at presentation, and there were no significant differences respect to serum CK, CK-MB and LDH levels [(187.4±24.1)U/L, (25.8±8.3)U/L and (189.2±35.3)U/L vs. (188.1±27.2)U/L, (26.9±7.4)U/L and (188.3±33.5)U/L] between patients with LFD- and with US-GPS-treated groups (P>0.05); the peripheral blood PLT, PCT, PDW and MPV in LFD-treated patients were (239.5±24.1)×109/L, (0.1±0.1)%, (16.2±2.3)% and (10.5±3.6)fl, not significantly different compared to [(242.1±26.3)×109/L, (0.1±0.1)%, (17.2±2.6)% and (9.8±3.1)fl] in US-GPS-treated patients (P>0.05); the incidences of fever, abdominal pain and distension, and vomiting in US-GPS-treated patients were 8.8%, 14.7% and 20.6%, all significantly lower than 29.0%, 41.9% and 48.4% (P<0.05) in LFD-treated patients; at the end of three month post-treatment, the relapse of HC in LFD-treated patients was 3.2%, significantly lower than 20.6%(P<0.05) in US-GPS-treated patients. Conclusion The efficacy of laparoscopic fenestration drainage is equivalent to that by ultrasound-guided puncture sclerotherapy in the treatment of patients with HC, with low recurrence of HC by the former, while with low complications by the latter, and the clinicians might make the decision appropriately.

Key words: Hepatic cyst, Laparoscopic fenestration drainage, Ultrasound-guided puncture sclerotherapy, Myocardial enzymes, Efficacy